For US Health Care Professionals Only
![Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]](/content/dam/novonordisk/esperoctpro/global/esperoct-logo.png){kind=logo}
Chief of Pediatric Hematology and Director of the Hemophilia Treatment Center, Mississippi Center for Advanced Medicine
In this video, Dr. Tami Singleton presents the clinical characteristics of, and her perspective on, extended half-life Esperoct®.
A portable reference with Esperoct® product information and clinical trial outcomes.
View our mechanism of action (MOA) video to see how Esperoct® uses PEGylation to extend half-life.
Please see full Prescribing Information and Important Safety Information.
This form will enable health care professionals and institutions to activate their Labcorp account and participate in the Novo Nordisk Lab Program. Email the completed form to fixsupport@labcorp.com.
Help your patients learn about hemophilia, with educational materials available to download and share.
Help your patients learn about hemophilia, with educational materials available to download and share.
Enter your zip code to find a Novo Nordisk Representative.
Operators are always available to assist with your product order.
Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.
